Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cryowise Technology is a specialized life sciences company focused on the development and manufacturing of advanced automated cryogenic storage solutions. A subsidiary of the Origincell Group, the company provides end-to-end cold chain management systems designed for the long-term preservation of biological samples, including cells, tissues, and blood products. Their product portfolio features fully automated liquid nitrogen storage systems that integrate robotics and intelligent software to ensure sample integrity and traceability. Cryowise serves a global clientele across biobanking, pharmaceutical research, and clinical cell therapy sectors, positioning itself as a critical infrastructure provider for the regenerative medicine industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Cryowise Technology.